Loading
IARC estimates 49,702 new cancer cases and 28,127 cancer deaths in Cuba in 2024; the commonest new cancers are trachea, bronchus and lung, prostate and colorectum. This page is assembled automatically from OnCo's data: 1 institution, 1 company, 1 person and 1 programme or law, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Trachea, bronchus and lung | 7,084 | 28.7 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Prostate | 6,930 | 59.3 | Prostate cancer |
| Colorectum | 5,744 | 21.7 | Colorectal cancer |
| Breast | 5,605 | 45.6 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Larynx | 1,935 | 8.3 | |
| Corpus uteri | 1,935 | 18.6 | Endometrial cancer |
| Bladder | 1,395 | 5.0 | Bladder & urothelial cancer |
| Cervix uteri | 1,355 | 13.7 | Cervical cancer |
| Stomach | 1,279 | 5.2 | Gastric & gastro-oesophageal junction cancer |
| Thyroid | 1,162 | 6.1 | Thyroid cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Trachea, bronchus and lung | 6,003 | 24.0 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Prostate | 3,783 | 27.0 | Prostate cancer |
| Colorectum | 3,132 | 11.6 | Colorectal cancer |
| Breast | 1,933 | 15.0 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Larynx | 1,017 | 4.3 | |
| Pancreas | 1,010 | 4.1 | Pancreatic ductal adenocarcinoma |
| Stomach | 935 | 3.7 | Gastric & gastro-oesophageal junction cancer |
| Liver and intrahepatic bile ducts | 894 | 3.6 | Hepatocellular carcinoma |
| Oesophagus | 892 | 3.9 | Oesophageal cancer |
| Bladder | 770 | 2.7 | Bladder & urothelial cancer |
No trial record in OnCo lists a site in Cuba. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
People whose main affiliation in OnCo is an institution or company in Cuba.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Cuba is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
A deep dive for Cuba is ranked 46 of 60 in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.